Welcome to BioLegend’s one-of-a-kind advanced search. Search by any one of the single fields below or narrow down your searches by using multiple parameters. Looking for an anti-mouse NK cell antibody for IHC? Or looking for a FITC-conjugated antibody against a human marker for dendritic cells to use for flow cytometry? Only BioLegend’s advanced search can provide you with the best answers. If you have further questions, please contact our technical service team at 858-768-5801.
Use this document lookup tool to find Current Product Datasheets, Certificates of Analysis, or MSDS for any antibody products you have purchased from BioLegend.
Use the search box below to perform a site search of BioLegend.com powered by Google™.
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions. The solution is free of unconjugated APC and unconjugated antibody.
Concentration:
0.2 mg/ml
Storage & Handling:
The antibody solution should be stored undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For immunofluorescent staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
COA:
Application Notes:
The UC10-4B9 antibody can enhance T cell co-stimulation by blocking CTLA-4 interactions with the B7 co-receptors, favoring CD28 interactions. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro stimulation, in vitro and in vivo blocking1-4 of ligand binding, and as ELISA capture antibody5. To reduce non-specific binding to cells bearing Fc-receptors, pre-incubation of cells with anti-mouse CD16/CD32, clone 93 (Cat. No. 101301/101302), is recommended prior to immunofluorescent staining. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 106306) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated anti-Armenian hamster IgG (Cat. No. 405501) second step, followed by SAv-PE (Cat. No. 405204)). The LEAF™ purified antibody (Endotoxin <0.1 EU/μg, Azide-Free, 0.2 μm sterile-filtered) is recommended for functional assays (Cat. No. 106308).
Application References:
1. Walunas TL, et al. 1994. Immunity 1:405. (Block IP) 2. Cilio CM, et al. 1998. J. Exp. Med. 188:1239. (Block) 3. Issazadeh S, et al. 1999. J. Immunol. 162:761. (Block) 4. McCoy K, et al. 1997. J. Exp. Med. 186:183. (Block) 5. Hsu HC, et al. 2007. J. Immunol. 178:5357. (ELISA Capture) 6. Sugita S, et al. 2010. Invest. Ophthalmol. Vis. Sci. 51:5783. PubMed
ConA stimulated C57BL/6 splenocytes (3 days) stained with UC10-4B9 APC and CD3e (145-2C11) PE
ConA stimulated C57BL/6 splenocytes (3 days) stained with Armenian Hamster IgG isotype APC and CD3e (145-2C11) PE
CD152, also known as CTLA-4 or Ly-56, is a 33 kD member of the immunoglobulin superfamily. It is expressed on activated T and B lymphocytes. CD152 is similar to CD28 in amino acid sequence, structure, and genomic organization and these two receptors share common B7 family counter-receptors (B7-1, B7-2). Whereas CD28 delivers a costimulatory signal in T cell activation, CTLA-4 negatively regulates cell-mediated immune responses. CD152 is thought to play a role in the induction and maintenance of immunological tolerance as well as the development of protective immunity and thymocyte regulation.
Other Names:
Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4), Ly-56
Structure:
Ig superfamily, 33 kD
Distribution:
Activated T and B cells
Function:
Negative regulator of T cell activation
Ligand Receptor:
CD80 (B7-1), CD86 (B7-2)
Antigen References:
1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Allison JP, et al. 1995. Science 270:932. 3. Waterhouse P, et al. 1995. Science 270:985. 4. Linsley PS, et al. 1991. J. Exp. Med. 174:561.
*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/terms). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.
This data display is provided for general comparisons between formats. Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors. If you need assistance with selecting the best format contact our expert technical support team.
Biotin anti-mouse CD152
Con A-stimulated (day-2) Balb/c mouse splenocytes stained with biotinylated UC10-4B9, followed by Sav-PE
PE anti-mouse CD152
Con A-stimulated BALB/c splenocytes (day-2) were stained with CD3 APC and UC10-4B9 PE
APC anti-mouse CD152
ConA stimulated C57BL/6 splenocytes (3 days) stained with UC10-4B9 APC and CD3e (145-2C11) PE
ConA stimulated C57BL/6 splenocytes (3 days) stained with Armenian Hamster IgG isotype APC and CD3e (145-2C11) PE
Brilliant Violet 421™ anti-mouse CD152
ConA stimulated C57BL/6 splenocytes (3 days) were stained with CD3 APC and CD152 (clone UC10-4B9) Brilliant Violet 421™ (top) or Armenian Hamster IgG Brilliant Violet 421™ isotype control (bottom).
